检索结果 - Bernard Escudier

Refine Results
  1. 1
    Emerging immunotherapies for renal cell carcinoma

    Emerging immunotherapies for renal cell carcinoma 由 Bernard Escudier

    出版 2012
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Axitinib for the Management of Metastatic Renal Cell Carcinoma

    Axitinib for the Management of Metastatic Renal Cell Carcinoma 由 Bernard Escudier, Martin Gore

    出版 2011
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 由 Bernard Escudier, Vesa Kataja

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Nivolumab in renal cell carcinoma: latest evidence and clinical potential

    Nivolumab in renal cell carcinoma: latest evidence and clinical potential 由 Camille Mazza, Bernard Escudier, Laurence Albigès

    出版 2016
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Sequential therapy in renal cell carcinoma

    Sequential therapy in renal cell carcinoma 由 Bernard Escudier, M. Gross Goupil, Christophe Massard, Karim Fizazi

    出版 2009
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Heat and Moisture Exchanger vs Heated Humidifier during Long-Term Mechanical Ventilation

    Heat and Moisture Exchanger vs Heated Humidifier during Long-Term Mechanical Ventilation 由 Benoît Misset, Bernard Escudier, Daniel Rivara, Bernard Leclercq, Gérard Nitenberg

    出版 1991
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma

    A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma 由 Chrystelle Brignone, Bernard Escudier, Caroline Grygar, Manon Marcu, Frédéric Triebel

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma

    Sunitinib: Ten Years of Successful Clinical Use and Study in Advanced Renal Cell Carcinoma 由 Robert J. Motzer, Bernard Escudier, Andrew Gannon, Robert A. Figlin

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma

    Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma 由 Hassan Izzedine, Lisa Derosa, Gwénaël Le Teuff, Laurence Albigès, Bernard Escudier

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

    Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma 由 S. Antoun, Vickie E. Baracos, Laura Birdsell, Bernard Escudier, Michael B. Sawyer

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib

    Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib 由 G. Mickisch, M. Gore, Bernard Escudier, Giuseppe Procopio, Stefan Walzer, Mark Nuijten

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma

    Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma 由 Robert J. Motzer, Bernard Escudier, Thomas Powles, Christian Scheffold, Toni K. Choueiri

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape

    Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape 由 Salem Chouaı̈b, Yosra Messai, Sophie Couvé, Bernard Escudier, Meriem Hasmim, Muhammad Zaeem Noman

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Prognostic factors for survival in patients with brain metastases from renal cell carcinoma

    Prognostic factors for survival in patients with brain metastases from renal cell carcinoma 由 St�phane Culine, Mohamed Békradda, Andrew Kramar, Annie Rey, Bernard Escudier, Jean-Pierre Droz

    出版 1998
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Metastatic renal cell carcinoma management

    Metastatic renal cell carcinoma management 由 Flávio Lobo Heldwein, Bernard Escudier, Gordon K. Smyth, Carlos Ary Vargas Souto, Guy Vallancien

    出版 2009
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  16. 16
    Insulin and IGFs in renal cancer risk and progression

    Insulin and IGFs in renal cancer risk and progression 由 Wojciech Solarek, Anna M. Czarnecka, Bernard Escudier, Zofia F. Bielecka, Fei Lian, Cezary Szczylik

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  17. 17
    TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma

    TiNivo: safety and efficacy of tivozanib-nivolumab combination therapy in patients with metastatic renal cell carcinoma 由 Laurence Albigès, Philippe Barthélémy, Marine Gross‐Goupil, Sylvie Négrier, Michael N. Needle, Bernard Escudier

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma

    Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma 由 Emilie Viey, Gaëlle Fromont, Bernard Escudier, Yannis Morel, Sylvie Da Rocha, Salem Chouaı̈b, Anne Caignard

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels

    Neovastat (Æ-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels 由 Gerald Batist, François Patenaude, P. Champagne, David Croteau, Carey Levinton, C. Hariton, Bernard Escudier, É. Dupont

    出版 2002
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography

    Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography 由 Nathalie Lassau, Serge Koscielny, Laurence Albigès, L. Chami, Baya Benatsou, Mohamed Chébil, Alain Roche, Bernard Escudier

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: